Published April 28, 2022
| Version v1
Report
Open
Mass drug administration for malaria transmission reduction
Authors/Creators
- 1. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA USA
- 2. Rollins School of Public Health, Emory University, Atlanta, GA USA
- 3. U.S. President's Malaria Initiative, Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA USA
- 4. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA USA & Global Malaria Programme, World Health Organization, Geneva, Switzerland
Description
Report considered by the WHO/GMP Guideline Development Group on Malaria Elimination for “Section 4.2.4.3 MDA to reduce transmission of P. falciparum in very low to low transmission settings”; “Section 4.2.6.4 MDA to reduce transmission of P. falciparum in moderate to high transmission settings”; and “Section 4.2.6.5 MDA to reduce transmission of P. vivax” of the WHO Guidelines for malaria, 3 June 2022.
Files
Schneider-et-al-2021-mda-for-transmission-reduction.pdf
Files
(2.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f0ca89202a010ed9c5ff7d9c9f7660d4
|
2.1 MB | Preview Download |